Crossmark

Direct Oral Anticoagulants in the Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: New Insights from Randomized Controlled Trials

Crossref DOI link: https://doi.org/10.1007/s40265-019-01084-2

Published Online: 2019-03-23

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rojas-Hernandez, Cristhiam M.

Oo, Thein Hlaing https://orcid.org/0000-0002-5201-731X
License Information

Text and Data Mining valid from 2019-03-23
More Information

Article History

First Online: 23 March 2019

Compliance with ethical standards

:

: No external funding was used in the preparation of this manuscript.

: Cristhiam M. Rojas-Hernandez has received funding for research from Daiichi Sankyo, is a preceptor/advisor for Bristol Myers Squibb, and is associate editor of PracticeUpdate-Elsevier. Thein Hlaing Oo is a site co-investigator for Jansen & Jansen and Daiichi Sankyo, and has received honoraria from Medical Education Speakers Network.

Document is current

Any future updates will be listed below